Enhabit, Inc. Files 8-K

Ticker: EHAB · Form: 8-K · Filed: Dec 9, 2025

Sentiment: neutral

Topics: regulatory-filing, financials

Related Tickers: ENHB

TL;DR

Enhabit (ENHB) filed an 8-K on 12/9/25 for Reg FD and financials.

AI Summary

Enhabit, Inc. filed an 8-K on December 9, 2025, to report information under Regulation FD and to file financial statements and exhibits. The company, formerly known as Encompass Health Home Health Holdings, Inc., is headquartered in Dallas, Texas.

Why It Matters

This filing indicates Enhabit, Inc. is providing updated regulatory disclosures and financial information to the public.

Risk Assessment

Risk Level: low — This is a routine regulatory filing with no immediate financial or operational news.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Enhabit, Inc.?

The primary purpose is to disclose information under Regulation FD and to file financial statements and exhibits.

When was this 8-K report filed?

The report was filed on December 9, 2025.

What was Enhabit, Inc.'s former name?

Enhabit, Inc.'s former name was Encompass Health Home Health Holdings, Inc.

Where are Enhabit, Inc.'s principal executive offices located?

Enhabit, Inc.'s principal executive offices are located at 6688 N. Central Expressway, Suite 1300, Dallas, Texas.

Under which section of the Securities Exchange Act is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-12-09 07:02:24

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure.*

Item 7.01. Regulation FD Disclosure.* As previously announced, Enhabit, Inc. (the "Company") will be participating in the BofA Securities 2025 Home Care Conference on December 9, 2025, at 2:50 p.m. CT. The Company's President and Chief Executive Officer, Barbara Jacobsmeyer, and Chief Financial Officer, Ryan Solomon, will participate in a fireside chat where they intend to discuss the Company's strategic focus and recent business developments, including an update to anticipated pricing impacts for 2026, among other matters. A copy of the investor presentation which will be discussed at the conference is attached to this report as Exhibit 99.1 and incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Investor Presentation of Enhabit, Inc.* 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document * The information in Item 7.01, including Exhibit 99.1, is being "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified as being incorporated therein by reference.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENHABIT, INC. By: /s/ Dylan C. Black Name: Dylan C. Black Title: General Counsel Dated: December 9, 2025

View on Read The Filing